Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ ImmunoCAP™ Fish, Shellfish and Mollusk Allergens

Catalog No. 14415901P
Click to view available options
Quantity:
10 Tests
16 Tests
Code:
Rf147
Rf206
Rf258
Rf303
Rf304
Rf307
Rf308
Rf311
Rf312
Rf313
Rf314
Rf320
Rf337
Rf346
Rf369
Rf381
Rf384
Rf413
Rf414
Rf415
Rf42
f204
f205
f207
f23
f24
f254
f290
f3
f338
f37
f40
f41
f50
f58
f59
f60
f61
f80
Common Name:
Abalone
Anchovy
Blue mussel
Cat fish
Chub mackerel
Clam
Crab
Crayfish
Fish (cod)
Gulf flounder
Haddock
Hake
Halibut
Herring
Jack mackerel, Scad
Langust (spiny lobster)
Lobster
Mackerel
Megrim
Octopus
Oyster
Pacific squid
Plaice
Pollock
Red snapper
Salmon
Sardine (Pilchard)
Sardine, Japanese Pilchard
Scallop
Shrimp
Snail
Sole
Squid
Swordfish
Tilapia
Trout
Tuna
Walleye pike
Whitefish (Inconnu)
This item is not returnable. View return policy
This item is not returnable. View return policy

Measure specifc IgE antibodies using ImmunoCAP™ allergens, an essential tool to aid in the diagnosis of allergic conditions.

Quantify specific IgE antibodies with ImmunoCAP™ Fish, Shellfish and Mollusk Allergens, essential tools to aid in the diagnosis of allergic conditions. IgE antibodies appear in human serum and plasma as a result of sensitization to a specific allergen. Measurement of circulating IgE antibodies provides an objective assessment of sensitization to an allergen. In general, low IgE antibody levels indicate a low probability of allergic disease, whereas high antibody levels to an allergen show a higher correlation with an allergic disease.

ImmunoCAP Specific IgE offers the laboratory:
  • Truly quantitative measuring range from 0.1 to 100 kUA/L
  • Intra-assay CV (%) comparable to routine clinical chemistry immunoassays
  • Excellent consistency over time, and between countries, systems, labs and persons
Expected test values
ImmunoCAP Specific IgE detects IgE antibodies in the range 0.1 to 100 kUA /l, where A represents allergen-specific antibodies. The result is reported quantitatively. In clinical practice, 0.35 kUA /l has commonly been used as a cut-off. A large number of studies have been performed to evaluate the clinical performance of ImmunoCAP Specific IgE tests in allergy diagnosis. Clinical performance is expressed as sensitivity, ranging from 84 to 95%, and specificity, ranging from 85 to 94%. Sensitivity and specificity were reported from multi-center studies including several hundred patients tested for a range of different allergens.
  • Specimen collection and preparation
  • Use serum and plasma (EDTA or heparin) samples from venous or capillary blood
  • Collect blood samples using standard procedures
  • Keep specimens at room temperature (RT) for shipping purposes only
  • Store at 2–8°C up to one week, otherwise store at –20°C
  • Avoid repeated freezing and thawing

Note: Blood samples for testing ImmunoCAP drugs and venom should be collected during or close to the event, preferably not later than 6 months after exposure. If the test result is negative and an IgE-mediated reaction is still strongly suspected, it is advisable to draw a new sample and repeat the test at 5 to 6 weeks.

The presence of specific IgE antibodies is useful to identify the allergens that elicit symptoms and signs of allergy in patients with respiratory allergic diseases including asthma, food allergy, and anaphylactic sensitivity.

Knowing IgE antibody levels provides guidance to clinicians to:
  • Identify offending allergens
  • Tailor advice to individual patients
  • Indicate development of tolerance (food allergy, specific immunotherapy)
  • Inform optimized individual medical treatment plans
  • Refer to specialists appropriately
  • Evaluate whether or not specific immunotherapy is an option

Specific IgE testing also aids in the identification of patients at risk of:
  • The allergy march – a progression of skin symptoms to respiratory symptoms
  • Severe symptoms including asthma exacerbations – a progression of mild symptoms to severe symptoms
  • Progression of recurrent symptoms to persistent symptoms

As in all diagnostic testing, a definitive clinical diagnosis should be made by the clinician after evaluation of all clinical and laboratory findings.
TRUSTED_SUSTAINABILITY

Specifications

Scientific Name Gadus morhua
Regulatory Status FDA Cleared
Code Type Fish, Shellfish, and Mollusk
Common Name Fish (cod)
Quantity 16 Tests
Code f3
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.